Skip to main content
. 2018 Nov 8;7(1):139–147. doi: 10.1002/fsn3.828

Figure 4.

Figure 4

Non‐alcoholic fatty liver disease (NAFLD) activity scores. (a) Photomicrographs of HE‐stained liver sections in each treatment group (b) NAFLD activity scores; comparison of steatosis scores (c), ballooning (d) and inflammation scores (e). Vehicle (black), Euglena (red), paramylon (green), telmisartan (gray). n.s. indicates “not significant”